FDA acceptance of Biologics License Application (BLA) for clemidsogene lanparvovec (RGX-121, partnered with Nippon Shinyaku) expected in May 2025 Pivotal data evaluating the safety and efficacy of ...

Jio Financial Q4 Results Today Highlights: Jio Financial Services Ltd ... a classic rounding bottom pattern on the short-term chart — a formation that typically signals a bullish reversal ...

Noodles & Company announced its first-quarter financial results for 2025 ... base open for at least 18 full periods. This measure highlights performance of existing restaurants, as the impact ...

Oxbridge Re Holdings Limited (NASDAQ: OXBR) announced its financial results for the first quarter of 2025, reporting an increase in net premiums earned to $595,000, up from $549,000 in the same ...

Hallador Energy Co (NASDAQ:HNRG) reduced total bank debt significantly, improving financial stability and liquidity. Uncertainty remains regarding the execution of definitive agreements with the ...

First Quarter 2025 Financial and Operational Highlights Key financial and operational highlights for the first quarter include: Riot's (NASDAQ: RIOT) vision is to be the world's leading Bitcoin ...

To tell the story you want with statistics, you don’t have to lie or fabricate data — though that happens, too. More often, ...

There's more to Monday's soaring stocks than the pause in crushing China tariffs. How to Think About the Stock Market When Earnings Guidance Becomes Meaningless The trade war puts profit outlooks ...

today reported business highlights and financial results for the first quarter ended March 31, 2025. “Delivering therapies that can positively impact patients’ lives is our mission,” said ...

("ProKidney” or the "Company"), a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease (CKD), today reported financial results and business highlights for the ...

reported financial results for the first quarter of fiscal year 2025, for the period ended March 31, 2025, and recent business highlights. Cash and Cash Equivalents as of March 31, 2025: $20.4M, Cash ...